Grave's Eye disease developing following radioiodine treatment for toxic nodular goitre

A A Tahrani; S Rangan; P Moulik

doi:10.1055/s-2007-970400

Grave's Eye disease developing following radioiodine treatment for toxic nodular goitre

A A Tahrani, S Rangan, P Moulik

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

The development of Grave's ophthalmopathy (GO) following radioiodine (RI) treatment for Grave's thyrotoxicosis, though controversial, is well described. The development of ophthalmopathy following RI treatment for toxic nodular goitre is much less recognised. We report a 49 year-old female patient who developed thyrotoxicosis and GO after receiving RI treatment for toxic nodular goitre and we also review the relevant literature.

Original language	English
Pages (from-to)	471-3
Number of pages	3
Journal	Experimental and Clinical Endocrinology and Diabetes
Volume	115
Issue number	7
DOIs	https://doi.org/10.1055/s-2007-970400
Publication status	Published - Jul 2007
Externally published	Yes

Keywords

Female
Goiter, Nodular
Graves Ophthalmopathy
Humans
Iodine Radioisotopes
Middle Aged
Radiation Injuries
Thyrotoxicosis
Case Reports
Journal Article

Access to Document

10.1055/s-2007-970400

Cite this

@article{acd17da5d8d84b0d807c5e3caad98a82,

title = "Grave's Eye disease developing following radioiodine treatment for toxic nodular goitre",

abstract = "The development of Grave's ophthalmopathy (GO) following radioiodine (RI) treatment for Grave's thyrotoxicosis, though controversial, is well described. The development of ophthalmopathy following RI treatment for toxic nodular goitre is much less recognised. We report a 49 year-old female patient who developed thyrotoxicosis and GO after receiving RI treatment for toxic nodular goitre and we also review the relevant literature.",

keywords = "Female, Goiter, Nodular, Graves Ophthalmopathy, Humans, Iodine Radioisotopes, Middle Aged, Radiation Injuries, Thyrotoxicosis, Case Reports, Journal Article",

author = "Tahrani, {A A} and S Rangan and P Moulik",

year = "2007",

month = jul,

doi = "10.1055/s-2007-970400",

language = "English",

volume = "115",

pages = "471--3",

journal = "Experimental and Clinical Endocrinology and Diabetes",

issn = "0947-7349",

publisher = "Thieme Publishing",

number = "7",

}

TY - JOUR

T1 - Grave's Eye disease developing following radioiodine treatment for toxic nodular goitre

AU - Tahrani, A A

AU - Rangan, S

AU - Moulik, P

PY - 2007/7

Y1 - 2007/7

N2 - The development of Grave's ophthalmopathy (GO) following radioiodine (RI) treatment for Grave's thyrotoxicosis, though controversial, is well described. The development of ophthalmopathy following RI treatment for toxic nodular goitre is much less recognised. We report a 49 year-old female patient who developed thyrotoxicosis and GO after receiving RI treatment for toxic nodular goitre and we also review the relevant literature.

AB - The development of Grave's ophthalmopathy (GO) following radioiodine (RI) treatment for Grave's thyrotoxicosis, though controversial, is well described. The development of ophthalmopathy following RI treatment for toxic nodular goitre is much less recognised. We report a 49 year-old female patient who developed thyrotoxicosis and GO after receiving RI treatment for toxic nodular goitre and we also review the relevant literature.

KW - Female

KW - Goiter, Nodular

KW - Graves Ophthalmopathy

KW - Humans

KW - Iodine Radioisotopes

KW - Middle Aged

KW - Radiation Injuries

KW - Thyrotoxicosis

KW - Case Reports

KW - Journal Article

U2 - 10.1055/s-2007-970400

DO - 10.1055/s-2007-970400

M3 - Article

C2 - 17647147

SN - 0947-7349

VL - 115

SP - 471

EP - 473

JO - Experimental and Clinical Endocrinology and Diabetes

JF - Experimental and Clinical Endocrinology and Diabetes

IS - 7

ER -

Grave's Eye disease developing following radioiodine treatment for toxic nodular goitre

Abstract

Keywords

Access to Document

Fingerprint

Cite this